180°C (2 min), (R)-3 t R = 5.0 min, (S)-3 t R = 5.5 min.
(E)-4-Methylhept-4-en-3-one (2)
A solution of KOH in MeOH (2 mL, 3 M) was added to diethylketone (7.74 g, 0.090 mol). The mixture was cooled to 4°C and propanal (2.61 g, 0.045 mol) was added dropwise. The reaction was stirred at room temperature overnight. Unreacted diethylketone was removed by distillation under reduced pressure and the residue was poured into diluted HCl and extracted with EtOAc. The organic phase was dried over anhydrous Na 2 SO 4 and concentrated in vacuo, to give a residue (ca.
3.5 g) which was submitted to dehydration by treatment with oxalic acid (0.40 g) in refluxing toluene (50 mL). The mixture was poured into water and extracted with EtOAc. The organic phase was dried over anhydrous Na 2 SO 4 and concentrated in vacuo, to give a residue which was purified by column chromatography, eluting with n-hexane and increasing quantity of EtOAc, to afford unsaturated ketone 2 (3.18 g, δ (ppm) 202.6, 143.4, 136.6, 30.4, 22.4, 13.2, 11.3, 8.9 ; GC-MS (EI) m/z (%) = 126 (M + , 20), 97
(100), 69 (90).
S3 (S)-4-Methylheptan-3-one ((S)-3)
A solution unsaturated ketone 2 in DMSO (1 mL, 400 mM, 0.4 mmol) was added to a potassium phosphate buffer solution (25 mL, 50 mM, pH 7.0) containing OYE1-W116V (5 mg), GDH (100 U), glucose (4 eq, 1.6 mmol, 288 mg) and NADP + (0.02 eq, 8 μmol, 5.9 mg). The reaction was incubated for 24 h in an orbital shaker at 30°C. The mixture was then extracted with EtOAc (3 × 10 mL), dried over anhydrous Na 2 SO 4 and purified by column chromatography (n-hexane with increasing amount of EtOAc) to afford compound (S) 
(R)-4-Methylheptan-3-one ((R)-3)
A solution unsaturated ketone 2 in DMSO (1 mL, 400 mM, 0.4 mmol) was added to a potassium phosphate buffer solution (25 mL, 50 mM, pH 7.0) containing OYE2.6 (5 mg), GDH (100 U), glucose (4 eq, 1.6 mmol, 288 mg) and NADP + (0.02 eq, 8 μmol, 5.9 mg). The reaction was incubated for 24 h in an orbital shaker at 30°C. The mixture was then extracted with EtOAc (3 × 10 mL), dried over anhydrous Na 2 SO 4 and purified by column chromatography (n-hexane with increasing amount of EtOAc) to afford compound (S)-3: ee = 99% (chiral GC); [] D = -21.9 (c 1.2, hexane). The spectroscopic data were in agreement with those of the enantiomer.
S4

General procedure for ER-mediated reduction of unsaturated ketone 2 (screening)
A solution of unsaturated ketone 2 in DMSO (10 μL, 500 mM, 5 mol) was added to a potassium phosphate buffer solution (1.0 mL, 50 mM, pH 7.0) containing glucose (20 μmol), NADP + (0.1 μmol), GDH (4 U) and the required purified or cell-free extract OYE (80-120 μg). The mixture was incubated for 24 h in an orbital shaker (160 rpm, 30°C). The solution was extracted with EtOAc (2 × 250 μL), centrifuging after each extraction (15000 g, 1.5 min), and the combined organic solutions were dried over anhydrous Na 2 SO 4 . Two replicates were performed for each biotransformation: no significant differences (less than 5%) were observed for conversion and enantiomeric excess values.
General procedure for ADH-mediated reduction of racemic 3 (screening)
A solution of ketone 3 in DMSO (10 μL, 500 mM, 5 mol) was added to a potassium phosphate buffer solution (1.0 mL, 50 mM, pH 7.0) containing glucose (20 μmol), NADP + (0.1 μmol) or NAD + (0.1 μmol) (according to the ADH preference), GDH (4 U) and the required ADH (200 μg).
The mixture was incubated for 24 h in an orbital shaker (160 rpm, 30°C). The solution was extracted with EtOAc (2 × 250 μL), centrifuging after each extraction (15000 g, 1.5 min), and the combined organic solutions were dried over anhydrous Na 2 SO 4 . The sterereoisomeric composition of the products was determined by GC analysis of the corresponding acetyl derivatives on a chiral column. Two replicates were performed for each biotransformation: no significant differences (less than 5%) were observed for conversion and stereoselectivity values.
S5
Representative GC chromatograms on chiral stationary phases 
